Osteocalcin promotes mineralization in bone microenvironment via regulating hydroxyapatite formation and integration.

Area of Science:

• Bone Biology
• Biomaterials Science
• Biochemistry

Background:

• The bone microenvironment involves complex matrix interactions crucial for bone health.
• Osteocalcin (OCN), a key non-collagenous bone protein, plays a role in this network, but its function in mineralization is debated.
• Understanding OCN's precise role is essential for developing treatments for bone pathologies.

Purpose of the Study:

• To investigate the function and mechanism of Osteocalcin (OCN) and its peptides in bone formation and mineralization.
• To clarify the controversial role of OCN in bone mineralization using integrated biological and biophysical approaches.

Main Methods:

• Utilized CRISPR/Cas9 technology to generate OCN knockout mice for in vivo studies.
• Employed Raman spectroscopy to analyze bone mineral composition and structure.
• Applied atomic force microscopy and nano-isothermal titration calorimetry to assess molecular interactions and mechanical properties.

Main Results:

• OCN knockout mice displayed significantly lower bone mineral density, reduced biomechanical strength, and impaired osteogenic differentiation of bone marrow stromal cells (BMSCs).
• Raman spectroscopy indicated smaller crystal size and decreased atomic order in Hydroxyapatite (HAp) within OCN-deficient bone.
• OCN and its peptide OC22 were identified as enhancers of collagen stiffness, binding to HAp.

Conclusions:

• Osteocalcin (OCN) acts as a positive regulator of bone mineralization.
• OCN enhances bone quality by increasing collagen stiffness and improving Hydroxyapatite crystal structure.
• These findings provide novel mechanistic insights for therapeutic strategies targeting bone diseases.